UNSPSC 51402501: Abecarnil

This classification denotes an anxiolytic with the molecular formula C24H24N2O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier IZM1PNJ3JL, chemically known as 9h-pyrido(3,4-b)indole-3-carboxylic acid, 1-(methoxymethyl)-6-(phenylmethoxy)-, 1-methylethyl ester but generally known as abecarnil, which bears US NIH Compound Identifier 65914. European Medicines Agency schedules Abecarnil in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07360MIG.

UNSPSC 51402501 Abecarnil (Commodity) covers pharmaceutical products state and local governments procure for public health and emergency response programs, though the recent opportunities block shows activity centered on naloxone and drug deactivation systems rather than abecarnil itself. Issuing bodies soliciting under this code include county health departments and community health initiatives. Seminole County, Florida represents the identifiable repeat or standout buyer in the recent activity.

Seminole County, Florida is the primary jurisdiction showing recent procurement activity under this code. In June 2026, Seminole County issued IFB 60459723LAS seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually, with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida; the response deadline was July 26, 2023. The contract carries a two-year initial term with an optional one-year renewal, includes a three-month probationary termination clause, and requires vendors to maintain workers' compensation, commercial general liability, and professional liability insurance. Bidders must comply with drug-free workplace certification, E-Verify, and federal regulations including the Clean Air Act and Federal Water Pollution Control Act, with potential FEMA funding. All shipping and delivery costs must be included in proposals submitted through Seminole County's e-Procurement Portal.